Enzo Biochem, Inc. (NYSE: ENZ)
$0.7201
N/A ( -1.88% ) 40.1K
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Market Data
Open
$0.7201
Previous close
$0.7201
Volume
40.1K
Market cap
$37.67M
Day range
$0.7210 - $0.7310
52 week range
$0.6823 - $1.4400
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 74 | Dec 16, 2024 |
3 | Insider transactions | 2 | Dec 02, 2024 |
ars | Annual reports | 1 | Nov 29, 2024 |
def | Proxies and info statements | 4 | Nov 27, 2024 |
8-k | 8K-related | 13 | Nov 25, 2024 |
8-k | 8K-related | 15 | Oct 30, 2024 |
10-k | Annual reports | 107 | Oct 29, 2024 |
8-k | 8K-related | 13 | Sep 24, 2024 |
8-k | 8K-related | 13 | Aug 14, 2024 |
8-k | 8K-related | 13 | Aug 02, 2024 |